Live Chat ×
Skip to main content

A Modeling and Experimental Investigation of Avidity Driven Antibody-Antigen Binding Kinetics

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • John Rhoden, Ph.D.

    John Rhoden, Ph.D. is a Senior Research Scientist in the Department of Drug Disposition at Eli Lilly and Company. He received his B.S. in Chemical Engineering from N.C. State University and a Ph.D. in Chemical Engineering from M.I.T. under the guidance of Prof. K. Dane Wittrup, after which he joined Eli Lilly and Company in 2012. At Lilly, Dr. Rhoden serves as a large molecule ADME project leader on discovery and early development project teams in a variety of therapeutic areas including oncology, immunooncology, autoimmunity, and kidney disease. Dr. Rhoden’s professional interests lie in using simple mathematical models to understand complex systems, interrogate hypotheses, and guide experiment design and interpretation.

September 23, 2019
Mon 12:30 PM EDT

Duration 1H 30M

This live web event has ended.